Rapastinel 1 mg | Purity Not Available
TargetMol
Rapastinel (GLYX-13) is an N-methyl-D-aspartate receptor (NMDAR) modulator.
More Information Supplier PageRapastinel
Search Results
ML281 2 mg | 99.77%
TargetMol
ML281
Tomivosertib 1 mg | 99.67%
TargetMol
Tomivosertib (eFT508) is a potent, highly selective MNK1 and MNK2 inhibitor with IC50 value of 1-2 nM.
More Information Supplier PageTomivosertib
CCG215022 1 mg | 97.46%
TargetMol
CCG215022 is a G protein-coupled receptor kinases (GRKs) inhibitor with IC50s of 0.15±0.07 μM, 0.38±0.06 μM and 3.9±1 μM for GRK2, 5 and 1, respectively.
More Information Supplier PageCCG215022
CCG215022 2 mg | 97.46%
TargetMol
CCG215022 is a G protein-coupled receptor kinases (GRKs) inhibitor with IC50s of 0.15±0.07 μM, 0.38±0.06 μM and 3.9±1 μM for GRK2, 5 and 1, respectively.
More Information Supplier PageCCG215022
CCG215022 25 mg | 97.46%
TargetMol
CCG215022 is a G protein-coupled receptor kinases (GRKs) inhibitor with IC50s of 0.15±0.07 μM, 0.38±0.06 μM and 3.9±1 μM for GRK2, 5 and 1, respectively.
More Information Supplier PageCCG215022
YM-90709 100 mg | 99.67%
TargetMol
YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.
More Information Supplier PageYM-90709
YM-90709 2 mg | 99.67%
TargetMol
YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.
More Information Supplier PageYM-90709
WIKI4 100 mg | 99.60%
TargetMol
WIKI4 is a potent inhibitor of Wnt/β-catenin signaling and tankyrase 2 (TNKS2).
More Information Supplier PageWIKI4
Ruxolitinib phosphate 25 mg | 99.86%
TargetMol
Ruxolitinib phosphate(INCB018424 phosphate) is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3.
More Information Supplier PageRuxolitinib phosphate
